Ionis CEO Sells $5.2M in Shares Amid Vesting and Strong Stock Rally
Ionis Pharmaceuticals CEO Brett P. Monia sold roughly $5.2 million worth of company shares on January 30, 2026, after receiving a larger grant the prior day from vested performance-based restricted stock units. The stock is trading near its 52-week high, supported by recent regulatory approvals and positive Phase 3 trial results, while company fina…